Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


21.08.2017

6 Acta Obstet Gynecol Scand
1 Aust N Z J Obstet Gynaecol
1 BMJ
3 Br J Cancer
7 Cancer
1 Clin Cancer Res
2 Eur J Cancer
4 Eur J Obstet Gynecol Reprod Biol
3 Fertil Steril
10 Gynecol Oncol
1 Hum Pathol
3 Int J Cancer
3 Int J Gynaecol Obstet
1 J Clin Oncol
2 JAMA
1 Obstet Gynecol
1 Oncogene
1 PLoS Genet
1 PLoS Med
11 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. ZHANG L, Rao F, Setzen R
    High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility.
    Acta Obstet Gynecol Scand. 2017;96:707-714.
    PubMed     Text format     Abstract available

  2. HELPMAN L, Yaniv A, Beiner ME, Aviel-Ronen S, et al
    Fertility preservation in women with borderline ovarian tumors- how does it impact disease outcome? A cohort study.
    Acta Obstet Gynecol Scand. 2017 Aug 16. doi: 10.1111/aogs.13203.
    PubMed     Text format     Abstract available

  3. LIANG H, Yin C, Dong X, Acharya G, et al
    Clusters of week-specific maternal gestational weight gain pattern and their association with birthweight:an observational cohort study.
    Acta Obstet Gynecol Scand. 2017 Aug 16. doi: 10.1111/aogs.13204.
    PubMed     Text format     Abstract available

  4. ACHARYA G
    Seven dangerous Ps of pregnancy and challenges of caring for pregnant women with complex needs.
    Acta Obstet Gynecol Scand. 2017;96:1037-1038.
    PubMed     Text format    

  5. BALDWIN HJ, Patterson JA, Nippita TA, Torvaldsen S, et al
    Maternal and neonatal outcomes following abnormally invasive placenta: a population-based record linkage study.
    Acta Obstet Gynecol Scand. 2017 Aug 14. doi: 10.1111/aogs.13201.
    PubMed     Text format     Abstract available

  6. FINNBOGADOTTIR SK, Glintborg D, Jensen TK, Kyhl H, et al
    Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age.
    Acta Obstet Gynecol Scand. 2017 Aug 14. doi: 10.1111/aogs.13200.
    PubMed     Text format     Abstract available


    Aust N Z J Obstet Gynaecol

  7. WHITELAW C, Calvert K, Epee M
    Keeping in time: Issues affecting the sustainability of obstetric emergency simulation training in outer metropolitan, rural and remote centres in Western Australia.
    Aust N Z J Obstet Gynaecol. 2017 Aug 14. doi: 10.1111/ajo.12678.
    PubMed     Text format     Abstract available


    BMJ

  8. COPP T, Jansen J, Doust J, Mol BW, et al
    Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?
    BMJ. 2017;358:j3694.
    PubMed     Text format    


    Br J Cancer

  9. CHEN Y, Wang DD, Wu YP, Su D, et al
    MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  10. MINLIKEEVA AN, Freudenheim JL, Cannioto RA, Eng KH, et al
    History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  11. OH H, Arem H, Matthews CE, Wentzensen N, et al
    Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  12. BENEVOLO M, Allia E, Gustinucci D, Rollo F, et al
    Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
    Cancer. 2017;125:212-220.
    PubMed     Text format     Abstract available

  13. FRICK MA, Vachani CC, Hampshire MK, Bach C, et al
    Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care.
    Cancer. 2017;123:1860-1868.
    PubMed     Text format     Abstract available

  14. PATADJI S, Li Z, Pradhan D, Zhao C, et al
    Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Cancer. 2016 Oct 24. doi: 10.1002/cncy.21791.
    PubMed     Text format     Abstract available

  15. BUYS SS, Sandbach JF, Gammon A, Patel G, et al
    A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
    Cancer. 2017 Jan 13. doi: 10.1002/cncr.30498.
    PubMed     Text format     Abstract available

  16. ZENNARO L, Vanzani P, Nicole L, Cappellesso R, et al
    Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
    Cancer. 2017;125:341-348.
    PubMed     Text format     Abstract available

  17. STIEKEMA A, Van de Vijver KK, Boot H, Broeks A, et al
    Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Mullerian origin from gastrointestinal cancer.
    Cancer. 2017;125:197-204.
    PubMed     Text format     Abstract available

  18. LONG ROCHE KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O, et al
    Risk-reducing salpingectomy: Let us be opportunistic.
    Cancer. 2017;123:1714-1720.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  19. RAGHAVAN S, Mehta P, Ward MW, Bregenzer ME, et al
    Personalized Medicine Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Clin Cancer Res. 2017 Aug 16. pii: clincanres.0133.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  20. MIRGHANI H, Jung AC, Fakhry C
    Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers.
    Eur J Cancer. 2017;78:105-115.
    PubMed     Text format     Abstract available

  21. LEE YC, Milne RL, Lheureux S, Friedlander M, et al
    Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
    Eur J Cancer. 2017;84:114-120.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  22. SAIJO M, Nakamura K, Masuyama H, Ida N, et al
    Reply to "Letter to the Editor" by M. Saijo et al. "Glasgow prognostic score is predictive of prognosis for patients with endometrial cancer ".
    Eur J Obstet Gynecol Reprod Biol. 2017 Aug 3. pii: S0301-2115(17)30370.
    PubMed     Text format    

  23. COLOMBO R, Pontoglio A, Bini M
    A STAG3 missense mutation in two sisters with primary ovarian insufficiency.
    Eur J Obstet Gynecol Reprod Biol. 2017 Aug 5. pii: S0301-2115(17)30375.
    PubMed     Text format    

  24. CAVKAYTAR S, Kokanali MK, Tasdemir U, Doganay M, et al
    Pregnancy outcomes after transvaginal sacrospinous hysteropexy.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:204-207.
    PubMed     Text format     Abstract available

  25. DEDDEN SJ, Geomini PMAJ, Huirne JAF, Bongers MY, et al
    Vaginal and Laparoscopic hysterectomy as an outpatient procedure: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:212-223.
    PubMed     Text format     Abstract available


    Fertil Steril

  26. BENDIFALLAH S, Roman H, Mathieu d'Argent E, Touleimat S, et al
    Colorectal endometriosis-associated infertility: should surgery precede ART?
    Fertil Steril. 2017 Aug 11. pii: S0015-0282(17)30497.
    PubMed     Text format     Abstract available

  27. KIM HJ, Adams JM, Gudmundsson JA, Arason G, et al
    Polycystic ovary morphology: age-based ultrasound criteria.
    Fertil Steril. 2017 Aug 11. pii: S0015-0282(17)30500.
    PubMed     Text format     Abstract available

  28. QIONG Z, Jie H, Yonggang W, Bin X, et al
    Clinical validation of pinopode as a marker of endometrial receptivity: a randomized controlled trial.
    Fertil Steril. 2017 Aug 11. pii: S0015-0282(17)30501.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  29. TATE S, Kato K, Nishikimi K, Matsuoka A, et al
    Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation study.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31176.
    PubMed     Text format     Abstract available

  30. KNAPP P, Bodnar L, Blachnio-Zabielska A, Swiderska M, et al
    Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31183.
    PubMed     Text format     Abstract available

  31. SENTER L, O'Malley DM, Backes FJ, Copeland LJ, et al
    Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31182.
    PubMed     Text format     Abstract available

  32. FORTNER RT, Damms-Machado A, Kaaks R
    Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31178.
    PubMed     Text format     Abstract available

  33. TARNEY CM, Tian C, Wang G, Dubil EA, et al
    Impact of age at diagnosis on racial disparities in endometrial cancer patients.
    Gynecol Oncol. 2017 Aug 8. pii: S0090-8258(17)31185.
    PubMed     Text format     Abstract available

  34. TORGESON A, Boothe D, Poppe MM, Suneja G, et al
    Disparities in care for elderly women with endometrial cancer adversely effects survival.
    Gynecol Oncol. 2017 Aug 9. pii: S0090-8258(17)31227.
    PubMed     Text format     Abstract available

  35. OLIVER KE, Brady WE, Birrer M, Gershenson DM, et al
    An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Gynecol Oncol. 2017 Aug 11. pii: S0090-8258(17)31226.
    PubMed     Text format     Abstract available

  36. GARCIA C, Lefkowits C, Pelkofski E, Blackhall L, et al
    Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse.
    Gynecol Oncol. 2017 Aug 11. pii: S0090-8258(17)31246.
    PubMed     Text format     Abstract available

  37. NASIOUDIS D, Chapman-Davis E, Frey MK, Caputo TA, et al
    Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Gynecol Oncol. 2017 Aug 10. pii: S0090-8258(17)31251.
    PubMed     Text format     Abstract available

  38. THAKER PH, Brady WE, Lankes HA, Odunsi K, et al
    A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary perito
    Gynecol Oncol. 2017 Aug 9. pii: S0090-8258(17)31186.
    PubMed     Text format     Abstract available


    Hum Pathol

  39. GUPTA M, Babic A, Beck AH, Terry K, et al
    TNF-alpha expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    Hum Pathol. 2016 Apr 8. pii: S0046-8177(16)30018.
    PubMed     Text format     Abstract available


    Int J Cancer

  40. WU YH, Huang YF, Chang TH, Chou CY, et al
    Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-kappaB-mediated IKKbeta expression.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30932.
    PubMed     Text format     Abstract available

  41. CHEN T, Brenner H, Fallah M, Jansen L, et al
    Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30930.
    PubMed     Text format     Abstract available

  42. VELENTZIS LS, Caruana M, Simms KT, Lew JB, et al
    How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccina
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30926.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  43. DIAS TZ, Passini R Jr, Tedesco RP, Lajos GJ, et al
    Evaluation of prenatal corticosteroid use in spontaneous preterm labor in the Brazilian Multicenter Study on Preterm Birth (EMIP).
    Int J Gynaecol Obstet. 2017 Aug 13. doi: 10.1002/ijgo.12297.
    PubMed     Text format     Abstract available

  44. DUFFY JMN, Hirsch M, Gale C, Pealing L, et al
    A systematic review of primary outcomes and outcome measure reporting in randomized trials evaluating treatments for pre-eclampsia.
    Int J Gynaecol Obstet. 2017 Aug 13. doi: 10.1002/ijgo.12298.
    PubMed     Text format     Abstract available

  45. KUMAR M, Sharma K, Singh S, Singh R, et al
    Use of first-trimester placenta growth factor concentration to predict hypertensive disorders of pregnancy in a low-risk Asian population.
    Int J Gynaecol Obstet. 2017 Aug 17. doi: 10.1002/ijgo.12301.
    PubMed     Text format     Abstract available


    J Clin Oncol

  46. ROSENTHAL AN, Fraser LS, Philpott S, Manchanda R, et al
    Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    J Clin Oncol. 2017 Feb 27:JCO2016699330. doi: 10.1200/JCO.2016.69.9330.
    PubMed     Text format     Abstract available


    JAMA

  47. YONKERS KA, Forray A, Smith MV
    Maternal Antidepressant Use and Pregnancy Outcomes.
    JAMA. 2017;318:665-666.
    PubMed     Text format    

  48. D'ONOFRIO BM, Sujan AC
    Maternal Antidepressant Use and Pregnancy Outcomes.
    JAMA. 2017;318:666-667.
    PubMed     Text format    


    Obstet Gynecol

  49. UPADHYAY UD, Johns NE, Meckstroth KR, Kerns JL, et al
    Distance Traveled for an Abortion and Source of Care After Abortion.
    Obstet Gynecol. 2017 Aug 14. doi: 10.1097/AOG.0000000000002188.
    PubMed     Text format     Abstract available


    Oncogene

  50. SOMASAGARA RR, Spencer SM, Tripathi K, Clark DW, et al
    RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS Genet

  51. SCOTT CA, Marsden AN, Rebagliati MR, Zhang Q, et al
    Nuclear/cytoplasmic transport defects in BBS6 underlie congenital heart disease through perturbation of a chromatin remodeling protein.
    PLoS Genet. 2017;13:e1006936.
    PubMed     Text format     Abstract available


    PLoS Med

  52. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    PubMed     Text format     Abstract available


    PLoS One

  53. AVUVIKA E, Masese LN, Wanje G, Wanyonyi J, et al
    Barriers and Facilitators of Screening for Sexually Transmitted Infections in Adolescent Girls and Young Women in Mombasa, Kenya: A Qualitative Study.
    PLoS One. 2017;12:e0169388.
    PubMed     Text format     Abstract available

  54. PAU CT, Mosbruger T, Saxena R, Welt CK, et al
    Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome.
    PLoS One. 2017;12:e0168870.
    PubMed     Text format     Abstract available

  55. HU J, Gu X, Tao X, Qian Y, et al
    Prevalence and Trends of HIV, Syphilis, and HCV in Migrant and Resident Men Who Have Sex with Men in Shandong, China: Results from a Serial Cross-Sectional Study.
    PLoS One. 2017;12:e0170443.
    PubMed     Text format     Abstract available

  56. JIANG Y, Chen C, Li L
    Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0170587.
    PubMed     Text format     Abstract available

  57. KORENROMP EL, Wi T, Resch S, Stover J, et al
    Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.
    PLoS One. 2017;12:e0170773.
    PubMed     Text format     Abstract available

  58. WONG WC, Zhao Y, Wong NS, Parish WL, et al
    Prevalence and risk factors of chlamydia infection in Hong Kong: A population-based geospatial household survey and testing.
    PLoS One. 2017;12:e0172561.
    PubMed     Text format     Abstract available

  59. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    PubMed     Text format     Abstract available

  60. VODSTRCIL LA, Twin J, Garland SM, Fairley CK, et al
    The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women.
    PLoS One. 2017;12:e0171856.
    PubMed     Text format     Abstract available

  61. DAVIES BM, McHugh M, Elgheriani A, Kolias AG, et al
    The reporting of study and population characteristics in degenerative cervical myelopathy: A systematic review.
    PLoS One. 2017;12:e0172564.
    PubMed     Text format     Abstract available

  62. CHONGTHAWONSATID S
    Inequity of healthcare utilization on mammography examination and Pap smear screening in Thailand: Analysis of a population-based household survey.
    PLoS One. 2017;12:e0173656.
    PubMed     Text format     Abstract available

  63. LEUNG DT, Lim PL, Cheung TH, Wong RR, et al
    Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
    PLoS One. 2016;11:e0160412.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: